These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36045873)

  • 1. Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin-Converting Enzyme 2 Correlates With Renin and Body Mass Index.
    Jehpsson L; Sun J; Nilsson PM; Edsfeldt A; Swärd P
    Front Physiol; 2020; 11():622179. PubMed ID: 33519526
    [No Abstract]   [Full Text] [Related]  

  • 2. RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
    Rothlin RP; Pelorosso F; Duarte M; Nicolosi L; Fernandez Criado I; Salgado MV; Vetulli H
    Rev Port Cardiol; 2024 Apr; 43(4):219-220. PubMed ID: 37940073
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
    Gonçalves J; Santos CD; Fresco P; Fernandez-Llimos F
    Rev Port Cardiol; 2024 Apr; 43(4):221-222. PubMed ID: 37918782
    [No Abstract]   [Full Text] [Related]  

  • 4. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.
    Coto E; Avanzas P; Gómez J
    Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of Correlation Between Soluble Angiotensin-Converting Enzyme 2 and Inflammatory Markers in Hospitalized COVID-19 Patients with Hypertension.
    Louisa M; Cahyadi D; Nilasari D; Soetikno V
    Infect Drug Resist; 2022; 15():4799-4807. PubMed ID: 36045873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.
    Chen R; Yang J; Gao X; Ding X; Yang Y; Shen Y; He C; Xiang H; Ke J; Yuan F; Cheng R; Lv H; Li P; Zhang L; Liu C; Tan H; Huang L
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1974-1983. PubMed ID: 33006442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.
    Loader J; Taylor FC; Lampa E; Sundström J
    J Am Heart Assoc; 2022 Jun; 11(11):e025289. PubMed ID: 35624081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
    de Abajo FJ; Rodríguez-Martín S; Lerma V; Mejía-Abril G; Aguilar M; García-Luque A; Laredo L; Laosa O; Centeno-Soto GA; Ángeles Gálvez M; Puerro M; González-Rojano E; Pedraza L; de Pablo I; Abad-Santos F; Rodríguez-Mañas L; Gil M; Tobías A; Rodríguez-Miguel A; Rodríguez-Puyol D;
    Lancet; 2020 May; 395(10238):1705-1714. PubMed ID: 32416785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.
    Úri K; Fagyas M; Mányiné Siket I; Kertész A; Csanádi Z; Sándorfi G; Clemens M; Fedor R; Papp Z; Édes I; Tóth A; Lizanecz E
    PLoS One; 2014; 9(4):e87845. PubMed ID: 24691269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis.
    de Jong VMT; Rousset RZ; Antonio-Villa NE; Buenen AG; Van Calster B; Bello-Chavolla OY; Brunskill NJ; Curcin V; Damen JAA; Fermín-Martínez CA; Fernández-Chirino L; Ferrari D; Free RC; Gupta RK; Haldar P; Hedberg P; Korang SK; Kurstjens S; Kusters R; Major RW; Maxwell L; Nair R; Naucler P; Nguyen TL; Noursadeghi M; Rosa R; Soares F; Takada T; van Royen FS; van Smeden M; Wynants L; Modrák M; ; Asselbergs FW; Linschoten M; ; Moons KGM; Debray TPA
    BMJ; 2022 Jul; 378():e069881. PubMed ID: 35820692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory elicitation, T-cell response and antibody production: an independent study of an inactivated entire virus vaccine (Coronavac).
    Souza-Silva GA; Aquino RCA; Sousa GF; Barros BRS; Lima MRCF; Cruz LCO; Marcos BFS; Silva AJD; Tales AVS; Diniz MV; Lima MMC; Sá IWA; Rodrigues FAC; Souza EB; Nascimento AVD; Vieira AM; Carvalho BM; Campelo Júnior EB; Freitas AC; Melo CML
    An Acad Bras Cienc; 2022; 94(3):e20211590. PubMed ID: 35766602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and corticosteroids: a narrative review.
    El-Saber Batiha G; Al-Gareeb AI; Saad HM; Al-Kuraishy HM
    Inflammopharmacology; 2022 Aug; 30(4):1189-1205. PubMed ID: 35562628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 mRNA vaccines: Platforms and current developments.
    Szabó GT; Mahiny AJ; Vlatkovic I
    Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.